Recombinant Human Norrin Protein，His & GST

Norrin is a secreted cysteine-rich growth factor that primarily plays a pivotal role in the development and maintenance of the retinal vasculature and the inner ear. It is encoded by the NDP gene, and mutations in this gene are implicated in Norrie disease, a rare genetic disorder leading to vision and hearing loss. Understanding the biological functions and mechanisms of Norrin is crucial for elucidating its role in angiogenesis and neural development. Recent studies have highlighted its interactions with Frizzled-4 and β-catenin in the Wnt signaling pathway, which are essential for endothelial cell communication and blood-brain barrier integrity. Given its significance in both normal physiological processes and disease states, characterizing Norrin as a recombinant protein is essential for exploring therapeutic applications. Researchers have been focusing on producing recombinant Norrin to investigate its structural properties, biological activities, and potential as a therapeutic agent for ocular and auditory disorders. By utilizing advanced protein engineering techniques, scientists aim to enhance the understanding of Norrin's functional mechanisms and develop targeted interventions that could mitigate the effects of Norrie disease and similar conditions. As studies progress, the promise of recombinant Norrin in regenerative medicine and its implications for treating vascular and sensory disorders continue to garner attention in the biomedical research community.